Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Interferon-β therapy specifically reduces pathogenic memory B cells in Multiple Sclerosis patients by inducing a FAS-mediated apoptosis.
Parametric Probability Distribution Functions for Axon Diameters of Corpus Callosum.
Parasites and immunotherapy: with or against?
Diffusion tensor imaging predicts cognitive function change following partial brain radiotherapy for low-grade and benign tumors.
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial.
Improvement of spasticity following intermittent theta burst stimulation in multiple sclerosis is associated with modulation of resting-state functional connectivity of the primary motor cortices.
The Dual-specificity phosphatase Dusp15 is regulated by Sox10 and Myrf in Myelinating Oligodendrocytes.
Poster 224 Giant Cell Myocarditis Masked by Acute Inflammatory Demyelinating Polyneuropathy: A Case Report.
LRP1 expression in microglia is protective during CNS autoimmunity.
Listeria rhombencephalitis mimicking a demyelinating event in an immunocompetent young patient.
Fatigue and Fatigability in Persons with Multiple Sclerosis.
Journal Club: Effect of comorbidity on mortality in multiple sclerosis.
Myeloid cells - targets of medication in multiple sclerosis.
The role of primary infection of Schwann cells in the aetiology of infective inflammatory neuropathies.
Assessing Four Quality Indicators for Multiple Sclerosis Management Through Patient-Reported Data.
Serial Diffusion Tensor Imaging of the Optic Radiations after Acute Optic Neuritis.
Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis.
Predicting early signs of dyslexia at a preliterate age by combining behavioral assessment with structural MRI.
Coping with multiple sclerosis-the role of social support.
Suicidal ideation in persons with neurological conditions: prevalence, associations and validation of the PHQ-9 for suicidal ideation.
Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.
Interleukin-13 immune gene therapy prevents CNS inflammation and demyelination via alternative activation of microglia and macrophages.
Recombinant Antibody Fragments For Neurodegenerative Diseases.
Update on infections with human herpesviruses 6A, 6B, and 7.
Promotion of the Unfolding Protein Response in Orexin/Dynorphin Neurons in Sudden Infant Death Syndrome (SIDS): Elevated pPERK and ATF4 Expression.
Pages
« first
‹ previous
…
802
803
804
805
806
807
808
809
810
…
next ›
last »